LION Oncology in collaboration with the Harley Street Clinic and the Leaders in Oncology Care (LOC) were pleased to host an evening meeting to launch new vascular oncology treatments in the HCA group in central London.

Selective internal radiation therapy (SIRT), drug-eluting bead transarterial chemoembolisation (DEB-TACE) and hepatic chemosaturation for the management of liver cancers are to be undertaken at the Harley Street Clinic under the LION governance pathways.

Dr Andrew Kennedy, Physican-in-Chief of Radiation Oncology at the Sarah Cannon Research Institute, Nashville, Tenesse, was the guest speaker at the meeting and spoke to an audience of oncologists and interventional radiologists about the extensive evidence base for SIRT in the management of liver cancers. There are several large phase III trials about the report on this technique – the first being SIRFLOX, due out in March 2015.